share_log

Morgan Stanley Upgrades MorphoSys to Overweight, Raises Price Target to $9.2

Morgan Stanley Upgrades MorphoSys to Overweight, Raises Price Target to $9.2

摩根士丹利将MorphoSys上调至增持,目标股价上调至9.2美元
Benzinga ·  2023/10/13 06:09

Morgan Stanley analyst James Quigley upgrades MorphoSys (NASDAQ:MOR) from Underweight to Overweight and raises the price target from $3.7 to $9.2.

摩根士丹利分析师詹姆斯·奎格利将Morphy Sys(纳斯达克股票代码:MOR)的评级从减持上调至增持,并将目标价从3.7美元上调至9.2美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发